We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Beckman Coulter Launches Automated, High-Throughput DxU Iris Urinalysis Solution in Europe

By LabMedica International staff writers
Posted on 30 Nov 2021
Print article
Image: DxU Iris Workcell (Photo courtesy of Beckman Coulter, Inc.)
Image: DxU Iris Workcell (Photo courtesy of Beckman Coulter, Inc.)

Beckman Coulter, Inc. (Brea, CA, USA) has announced the European launch of the DxU Iris Workcell, a fully-automated system that streamlines urinalysis workflow and reduces manual microscopy.

A routine urinalysis is one the most frequently ordered tests, representing up to 30% of all samples received in the lab. Many of these samples require a lab technician to perform a manual inspection, which causes workflow disruption and a substantial increase in workload. Whether it is confirming the analyzer's findings or identifying unique particle types, manual microscopic reviews are time-consuming and can take up to six times longer per sample than with an automated system. Automating the routine urinalysis workflow with the DxU Iris Workcell reduces sample subjectivity and variability, helping laboratories of all sizes standardize processes, drive faster turnaround time and deliver quality results.

The DxU Iris Workcell pairs the DxU 850m Iris or DxU 840m Iris urine microscopy analyzer with the Arkray AUTION MAX 4030 urine chemistry analyzer to create a scalable, fully automated urinalysis solution. The workcell was developed with proprietary Digital Flow Morphology technology with Auto-Particle Recognition (APR) Software to enable laboratories to deliver standardized results using artificial intelligence (AI). This industry-leading technology isolates, identifies and characterizes urine particles to provide immediate, accurate and reproducible results verified directly on the screen.

"There is no doubt that the pandemic has intensified pressure on the clinical laboratory," said Dr. Peter Soltani, senior vice president & general manager, hematology, urinalysis & workflow information technology solutions at Beckman Coulter. "In this pressurized environment, manual reviews are particularly onerous because they are labor-intensive, taking time and focus away from scientific work. We designed the DxU Iris Workcell to allow urinalysis operators to automatically classify sediment particles, minimizing the need for human intervention."

“We know that it’s important to our customers that any new analyser they bring into the lab makes the workflow better and is easy to use with minimal maintenance,” said Jose Antonio Crespo Solans, Senior Director, EU Sales& Marketing. “With our industry-leading technology operators will be able to isolate, identify, and characterise urine particles to provide immediate, accurate, and reproducible results verified directly on the screen. And with our load-and-go walk away capabilities and EFR technology, we help to minimise operator intervention and interruptions.”

Related Links:
Beckman Coulter, Inc. 

Automated ELISA-IFA-BLOT Processor AP 22
New
Gold Supplier
Influenza Type A & B Test
Influenza A+B DUO
New
Semi-Auto Biochemistry Analyzer
TC-ChemX50
New
3-Part Diff Hematology Analyzer
UDIHEM III PLUS

Print article

Channels

Molecular Diagnostics

view channel
Image: A new machine rapidly and robustly separates cancer cells from blood samples (Photo courtesy of DGIST)

System Separates Circulating Tumor Cells from Blood Samples, Improves Cancer Diagnostics

Circulating tumor cells are cells that break off from cancers and are released into the blood stream. They can go on to form the seeds for new tumor formation in other parts of the body, known as metastases.... Read more

Industry

view channel
Image: Fujirebio has acquired ADx NeuroSciences for 40 million Euros (Photo courtesy of Pexels)

Fujirebio's Belgian Acquisition Targets Neurodegenerative Diagnostics

Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.